---
figid: PMC7927447__TJH-38-1-g2
figtitle: Action of targeted therapies in PIRDs
organisms:
- NA
pmcid: PMC7927447
filename: TJH-38-1-g2.jpg
figlink: pmc/articles/PMC7927447/figure/f2/
number: F2
caption: 'Mechanisms of action of targeted therapies in PIRDs. (A) CTLA4-Fc-fusion
  proteins (abatacept, belatacept). (B) Inhibitors of the PI3K complex (leniolisib,
  nemiralisib, seletalisib) and mTOR inhibitor (sirolimus). The PI3K signaling pathway
  activates AKT serine/threonine kinase, which then phosphorylates mTOR and promotes
  protein translation, cell growth, survival, and proliferation. (C) JAK inhibitors
  (jakinibs) and anti-IL-6 (tocilizumab). Created by BioRender.com.PTEN: Phosphatase
  and tensin homolog; PDK1: phosphoinositide-dependent kinase-1; AKT: AKT serine/threonine
  kinase; S6K: ribosomal protein S6 kinase; 4EBP1: eukaryotic translation initiation
  factor 4E-binding protein; mTOR: mechanistic target of rapamycin complex.'
papertitle: Primary Immune Regulatory Disorders and Targeted Therapies.
reftext: Burcu KolukÄ±sa, et al. Turk J Haematol. 2021 Mar;38(1):1-14.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8772704
figid_alias: PMC7927447__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7927447__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7927447__TJH-38-1-g2.html
  '@type': Dataset
  description: 'Mechanisms of action of targeted therapies in PIRDs. (A) CTLA4-Fc-fusion
    proteins (abatacept, belatacept). (B) Inhibitors of the PI3K complex (leniolisib,
    nemiralisib, seletalisib) and mTOR inhibitor (sirolimus). The PI3K signaling pathway
    activates AKT serine/threonine kinase, which then phosphorylates mTOR and promotes
    protein translation, cell growth, survival, and proliferation. (C) JAK inhibitors
    (jakinibs) and anti-IL-6 (tocilizumab). Created by BioRender.com.PTEN: Phosphatase
    and tensin homolog; PDK1: phosphoinositide-dependent kinase-1; AKT: AKT serine/threonine
    kinase; S6K: ribosomal protein S6 kinase; 4EBP1: eukaryotic translation initiation
    factor 4E-binding protein; mTOR: mechanistic target of rapamycin complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - Pten
  - Akt
  - Crtc
  - Stat92E
  - Tcr
  - Thor
  - Lon
  - schlank
  - APC
  - PROC
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - CRTC2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - TCPT
  - TOE1
  - LONP1
  - TCR
---
